For patients with a rare cancer called gastrointestinal stromal tumor, or GIST, there’s been no effective treatment other than surgery. That may change.
A new drug has helped more than three-quarters of GIST patients taking it. In these patients, surgery either failed or was impossible. The drug shrank or stopped tumor growth for at least 6 months from the beginning of treatment.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.